Convective dialysis therapies, current status and perspective

Area of Science:

• Nephrology
• Renal Replacement Therapy
• Blood Purification

Background:

• Convective dialysis therapies (hemofiltration, hemodiafiltration) emerged in the 1970s but faced limitations.
• Current chronic hemodialysis (HD) has plateaued in improving patient survival despite advancements.
• The HEMO study indicated that high-dose HD with high-flux membranes offers limited additional survival benefit.

Purpose of the Study:

• To re-evaluate the clinical potential of convective dialysis therapies.
• To highlight new evidence supporting the efficacy of convective treatments.
• To explore the expanded solute removal and hemodynamic benefits of convection.

Main Methods:

• Review of recent evidence supporting convective dialysis therapies.
• Comparison of solute removal spectrum between convection and diffusion.
• Assessment of hemodynamic stability in convective therapies versus modern HD.
• Analysis of observational data on survival benefits with high-volume convection.

Main Results:

• Convection removes a broader range of uremic toxins compared to diffusion.
• Convective therapies demonstrate sustained hemodynamic stability.
• Observational data suggests a survival advantage for patients receiving large-volume convective treatments.
• Convective therapies are effective for acute renal failure and may expand to ICU blood purification.

Conclusions:

• Convective dialysis therapies, including hemofiltration and hemodiafiltration, are gaining renewed interest due to limitations in HD efficacy.
• The enhanced solute clearance and hemodynamic stability of convective methods offer significant advantages for dialysis patients.
• Further development of membranes may broaden the application of convective therapies in critical care settings.